Skip to main content
    S

    Solid Biosciences LLC (SLDB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.48
    -0.36 (-5.26%)

    Market Cap: $763.42M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    44%(16/36)
    Avg Surprise
    -3.24%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 4, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.41
    Range-$0.51 - -$0.36
    16 analysts
    Revenue Consensus
    N/A
    RangeN/A
    12 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.41
    Range-$0.53 - -$0.35
    8 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.45+9.7%
    60d ago-$0.44+8.0%
    30d ago-$0.43+6.6%
    7d ago-$0.43+6.6%
    Current-$0.41
    Revenue Consensus
    N/A
    RangeN/A
    7 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-4.89xFCF Yield-20.47%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-76.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio11.99xQuick Ratio11.99x
    Trading Statistics
    Beta2.63Avg Volume1.31M
    52-Week High$11.4552-Week Low$4.24

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 9.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 46.8, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$6.77
    SMA 20$6.48
    SMA 50$7.12
    SMA 200$7.68
    EMA 10$6.75
    EMA 20$6.67
    EMA 50$7.08
    EMA 200$7.35

    MACD

    Line: 0.00Signal: -0.11Hist: 0.11

    ADX

    ADX: 21.9+DI: 23.6-DI: 24.1

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down12.0
    PSAR$7.83

    Bollinger Bands

    Upper Band$7.38
    Lower Band$5.59
    %B Position2768%(Upper)
    Band Width0.50

    RSI (14-Day)

    Neutral
    46.8

    Momentum Oscillators

    Stoch %K47.7
    Stoch %D64.5
    Williams %R-67.9
    ROC (10d)8.0%
    Momentum0.48
    CCI (20d)28.2
    MFI (14d)65.0

    Volatility Measures

    ATR (14d)$0.50(7.7%)
    StdDev (20d)0.45
    Hist Vol78.6%(High)

    Volume Flow

    VWAP$6.62
    OBV56.5M
    AD Line32.5M
    CMF (20d)0.065

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio0.7x
    VWMA (20d)$6.57

    Pivot Points

    R3$7.56
    R2$7.30
    R1$7.07
    Pivot Point$6.82
    S1$6.59
    S2$6.33
    S3$6.10

    Advanced Oscillators

    TSI-0.11
    Ultimate Osc49.2
    KST7.22

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about SLDB

    News

    SLDB Valuation

    P/FCF
    -4.9x
    P/B
    2.9x
    All SLDB metrics

    SLDB Profitability: Margins, ROIC and FCF

    Solid Biosciences LLC (SLDB) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -76.9%
    FCF yield
    -20.5%
    SLDB financial statements

    Solid Biosciences LLC Competitors

    The companies most similar to Solid Biosciences LLC (SLDB) include Sana Biotechnology, Syndax Pharmaceuticals and DBV Technologies.

    Sector: Healthcare

    Companies most similar to Solid Biosciences LLC

    SLDB Analyst Ratings

    Solid Biosciences LLC (SLDB) has a Buy consensus from 14 analysts: 14 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    14
    Strong Buy
    5
    Buy
    9
    Hold
    0
    Sell
    0
    Strong Sell
    0
    SLDB stock forecast

    SLDB Bull Case vs Bear Case

    Bull case

    • 100.0% of SLDB's analyst ratings are Buy or Strong Buy.

    Bear case

    • SLDB beat EPS estimates in 37.5% of its last 8 reported quarters.
    • SLDB's quarterly revenue changed -100.0% year over year.

    SLDB Earnings: Beat Rate and Next Report

    Solid Biosciences LLC (SLDB) beat the EPS estimate in 3 of the last 8 quarters (37.5%). Its next report is expected on Mar 4, 2027.

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -4.9%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.41
    SLDB earnings history

    SLDB Earnings Date

    SLDB reports Mar 4, 2027. The date is estimated.

    SLDB ETF Holders

    See insider activity

    Updated Nov 4, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About SLDB

    When does SLDB report earnings?

    Solid Biosciences LLC (SLDB) is expected to report earnings on Mar 4, 2027.

    Does SLDB pay dividends?

    Solid Biosciences LLC (SLDB) does not currently pay a regular dividend.

    What is SLDB's market cap?

    Solid Biosciences LLC (SLDB) has a market capitalization of $763.42M with a current stock price of $6.48.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.